Header cover image

Japanese (NIKKEI) Healthcare Sector Analysis

UpdatedMay 01, 2024
DataAggregated Company Financials
Companies205
  • 7D3.3%
  • 3M0.1%
  • 1Y4.8%
  • YTD3.6%

The Healthcare industry is up 1.1% in the last week, with Daiichi Sankyo Company up 15%. This takes the industry's 12 month performance to a gain of 3.0%. As for the next few years, earnings are expected to grow by 12% per annum.

Sector Valuation and Performance

Has the Japanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 01 May 2024JP¥65.2tJP¥34.8tJP¥2.0t17.3x32.9x1.9x
Fri, 29 Mar 2024JP¥66.9tJP¥35.1tJP¥2.0t18.2x34.1x1.9x
Sun, 25 Feb 2024JP¥67.2tJP¥35.1tJP¥2.0t18.7x34.3x1.9x
Tue, 23 Jan 2024JP¥66.6tJP¥35.0tJP¥2.2t18.7x30.9x1.9x
Thu, 21 Dec 2023JP¥62.9tJP¥35.0tJP¥2.2t18.1x29.2x1.8x
Sat, 18 Nov 2023JP¥63.1tJP¥35.0tJP¥2.2t17.3x29.2x1.8x
Mon, 16 Oct 2023JP¥62.3tJP¥34.5tJP¥2.3t17.6x27.4x1.8x
Wed, 13 Sep 2023JP¥64.9tJP¥34.5tJP¥2.3t17.7x28.6x1.9x
Fri, 11 Aug 2023JP¥64.6tJP¥34.5tJP¥2.3t18.9x28.6x1.9x
Sun, 09 Jul 2023JP¥62.8tJP¥33.9tJP¥2.3t18.1x27.1x1.9x
Tue, 06 Jun 2023JP¥66.5tJP¥33.9tJP¥2.3t18.4x28.8x2x
Thu, 04 May 2023JP¥62.9tJP¥33.7tJP¥2.3t17.8x27.9x1.9x
Sat, 01 Apr 2023JP¥60.3tJP¥33.5tJP¥2.3t16.8x26.2x1.8x
Mon, 27 Feb 2023JP¥59.1tJP¥33.5tJP¥2.3t16.8x25.7x1.8x
Wed, 25 Jan 2023JP¥60.6tJP¥32.4tJP¥2.2t16.1x27.9x1.9x
Fri, 23 Dec 2022JP¥60.9tJP¥32.4tJP¥2.2t15.6x28x1.9x
Sun, 20 Nov 2022JP¥64.1tJP¥32.4tJP¥2.2t15.6x29.4x2x
Tue, 18 Oct 2022JP¥63.8tJP¥31.7tJP¥2.3t15.7x28.2x2x
Thu, 15 Sep 2022JP¥62.7tJP¥31.7tJP¥2.3t16x27.7x2x
Sat, 13 Aug 2022JP¥62.6tJP¥31.7tJP¥2.3t16x27.7x2x
Mon, 11 Jul 2022JP¥60.3tJP¥31.3tJP¥2.3t16x26.1x1.9x
Wed, 08 Jun 2022JP¥57.9tJP¥31.5tJP¥2.3t15.7x25.3x1.8x
Fri, 06 May 2022JP¥58.9tJP¥31.0tJP¥2.5t16.7x24.1x1.9x
Sun, 03 Apr 2022JP¥58.3tJP¥30.7tJP¥2.4t17.2x24.4x1.9x
Tue, 01 Mar 2022JP¥58.3tJP¥30.7tJP¥2.4t16.3x24.3x1.9x
Thu, 27 Jan 2022JP¥57.6tJP¥30.3tJP¥2.4t16.6x23.8x1.9x
Sat, 25 Dec 2021JP¥63.8tJP¥30.3tJP¥2.4t17.3x26.3x2.1x
Mon, 22 Nov 2021JP¥66.6tJP¥30.3tJP¥2.4t18.9x27.5x2.2x
Wed, 20 Oct 2021JP¥67.5tJP¥29.7tJP¥2.2t20.3x30.1x2.3x
Fri, 17 Sep 2021JP¥71.0tJP¥29.4tJP¥2.2t21.7x31.9x2.4x
Sun, 15 Aug 2021JP¥65.1tJP¥29.5tJP¥2.2t20.3x29.3x2.2x
Thu, 10 Jun 2021JP¥63.5tJP¥28.7tJP¥2.0t20.9x31.3x2.2x
Price to Earnings Ratio

30.9x


Total Market Cap: JP¥62.7tTotal Earnings: JP¥2.0tTotal Revenue: JP¥28.7tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Healthcare Sector Price to Earnings3Y Average 28x202220232024
Current Industry PE
  • Investors are optimistic on the Japanese Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 32.1x which is higher than its 3-year average PE of 28.0x.
  • The industry is trading close to its 3-year average PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 6.6% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare sector?

JP Market2.54%
Healthcare3.26%
Biotech7.48%
Pharma3.94%
Medical Equipment3.12%
Life Sciences2.42%
Healthcare Services0.80%
Healthtech-6.50%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 33.0x.
    • Analysts are expecting annual earnings growth of 17.3%, which is higher than its past year's earnings decline of 19.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 31% over the next 5 years.
  • This is better than its past earnings decline of 9.3% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 8.9% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4568 Daiichi Sankyo CompanyJP¥5.36k15.0%
+JP¥1.3t		14.4%PE51.2x
7741 HOYAJP¥18.47k5.3%
+JP¥324.2b		23.9%PE38.8x
4578 Otsuka HoldingsJP¥6.74k6.3%
+JP¥218.2b		43.8%PE30.1x
4523 EisaiJP¥6.50k6.8%
+JP¥118.2b		-18.4%PE41.1x
4543 TerumoJP¥2.69k2.8%
+JP¥109.1b		31.6%PE40.4x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4568

JP¥5,364.00

Daiichi Sankyo Company

7D

15.0%

1Y

14.4%

4587

JP¥2,022.00

PeptiDream

7D

24.7%

1Y

10.9%

PeptiDream Inc.'s (TSE:4587) 42% Price Boost Is Out Of Tune With Revenues

Apr 30
PeptiDream Inc.'s (TSE:4587) 42% Price Boost Is Out Of Tune With Revenues

4528

JP¥2,276.00

Ono Pharmaceutical

7D

-0.6%

1Y

-17.5%

4503

JP¥1,514.00

Astellas Pharma

7D

1.5%

1Y

-27.2%

Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 29
Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

9158

JP¥1,699.00

CUC

7D

-26.2%

1Y

n/a

Results: CUC Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Apr 28
Results: CUC Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

2413

JP¥1,691.50

M3

7D

-10.2%

1Y

-45.2%

4502

JP¥4,153.00

Takeda Pharmaceutical

7D

0.8%

1Y

-9.3%

4519

JP¥5,050.00

Chugai Pharmaceutical

7D

-2.6%

1Y

40.2%

Chugai Pharmaceutical Co., Ltd. (TSE:4519) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Apr 26
Chugai Pharmaceutical Co., Ltd. (TSE:4519) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

4151

JP¥2,649.00

Kyowa Kirin

7D

-0.2%

1Y

-13.4%

Kyowa Kirin (TSE:4151) Is Due To Pay A Dividend Of ¥29.00

Apr 25
Kyowa Kirin (TSE:4151) Is Due To Pay A Dividend Of ¥29.00

4523

JP¥6,502.00

Eisai

7D

6.8%

1Y

-18.4%

4887

JP¥5,882.00

Sawai Group Holdings

7D

-5.1%

1Y

49.9%

Is There An Opportunity With Sawai Group Holdings Co., Ltd.'s (TSE:4887) 41% Undervaluation?

Apr 22
Is There An Opportunity With Sawai Group Holdings Co., Ltd.'s (TSE:4887) 41% Undervaluation?

4578

JP¥6,742.00

Otsuka Holdings

7D

6.3%

1Y

43.8%

Is There An Opportunity With Otsuka Holdings Co., Ltd.'s (TSE:4578) 24% Undervaluation?

Apr 20
Is There An Opportunity With Otsuka Holdings Co., Ltd.'s (TSE:4578) 24% Undervaluation?

4506

JP¥399.00

Sumitomo Pharma

7D

-2.4%

1Y

-51.0%

7741

JP¥18,470.00

HOYA

7D

5.3%

1Y

23.9%

A Look At The Fair Value Of HOYA Corporation (TSE:7741)

Apr 12
A Look At The Fair Value Of HOYA Corporation (TSE:7741)

4543

JP¥2,693.50

Terumo

7D

2.8%

1Y

31.6%

Investors Still Waiting For A Pull Back In Terumo Corporation (TSE:4543)

Apr 12
Investors Still Waiting For A Pull Back In Terumo Corporation (TSE:4543)

7071

JP¥2,183.00

Amvis Holdings

7D

-7.1%

1Y

-24.2%

Amvis Holdings, Inc.'s (TSE:7071) Price In Tune With Earnings

Mar 15
Amvis Holdings, Inc.'s (TSE:7071) Price In Tune With Earnings